Table 1 Periostin expression in various cancer cell lines
Cell line | Origin | POSTN/ACTB1 |
|---|---|---|
U2OS | Osteosarcoma | 3.5 ± 1.7 |
LB96 | Ewing sarcoma | 0 |
LB23-1 | Rhabdomyosarcoma | 0.1 ± 0.1 |
Hela | Cervical cancer | 3.0 ± 0.4 |
PA-1 | Ovarian teratocarcinoma | 1.4 ± 0.1 |
LB37-1 | NSCLC | 2.8 ± 0.6 |
LB85 | SCLC | 3.4 ± 0.2 |
LB92 | SCLC | 0.6 ± 0.2 |
LB1047 | Renal cell carcinoma | 0.8 ± 0.2 |
BB64 | Renal cell carcinoma | 0.08 ± 0.01 |
LB108 | Colorectal cancer | 0 |
MCF7 | Breast cancer | 0 |
Hs578T | Breast cancer | 3693 ± 86 |
Panc-1 | Pancreatic carcinoma | 0 |
Capan-1 | Pancreatic carcinoma | 0 |
Huh-7 | Hepatocarcinoma | 0.3 ± 0.07 |
LB831 | Bladder carcinoma | 1748 ± 74 |
MZGC3 | Stomach cancer | 0 |
A172 | Glioblastoma | 45 ± 4 |
MZ2 | Melanoma | 2.3 ± 0.7 |
LB39 | Melanoma | 0.5 ± 0.03 |
LB2586-7 | Melanoma | 3.4 ± 0.3 |
LB2201-3 | Melanoma | 4.2 ± 0.4 |
A375 | Melanoma | 4.7 ± 1.2 |